In conclusion, we demonstrate that the pretreatment with G-CSF can significantly enhance the cytotoxic activity of ATO by upregulating the expression of AQP9 in non-APL AML cells in vitro and in vivo (as shown in Fig. 6G). The gene discussed is CSF3; the disease is acute promyelocytic leukemia.